VVM
Versant Venture Management Portfolio holdings
AUM
$82.1M
This Quarter Return
+21.78%
1 Year Return
-26.22%
3 Year Return
+73.87%
5 Year Return
-1.11%
10 Year Return
+1,578.11%
AUM
$84.3M
AUM Growth
+$84.3M
(+76%)
Cap. Flow
+$28M
Cap. Flow
% of AUM
33.22%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Repare Therapeutics
RPTX
|
$28M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Repare Therapeutics
RPTX
$71.7M
| $28M | 33.22% | +2,646,657 | New | +$28M |
|
2
CRISPR Therapeutics
CRSP
$4.71B
| $28M | 33.2% | 498,558 | – | – |
|
3
Adverum Biotechnologies
ADVM
$64.6M
| $8.06M | 9.56% | 5,068,233 | – | – |
|
|
GRTS
4
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $6.94M | 8.24% | 3,561,150 | – | – |
|
|
CBAY
5
DELISTED
Cymabay Therapeutics
CBAY
| $5.95M | 7.06% | 543,753 | – | – |
|
6
Passage Bio
PASG
$22.7M
| $4.67M | 5.54% | 4,959,769 | – | – |
|
7
Aligos Therapeutics
ALGS
$73.3M
| $2.25M | 2.67% | 2,320,381 | – | – |
|
|
UTRS
8
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
| $429K | 0.51% | 1,673,700 | – | – |
|